News | Lung Imaging | March 11, 2016

Clean energy combustion technology has been used to successfully hyperpolarize krypton gas for MRI scanning of the lungs

lung disease, MRI scans, contrast agent, hyperpolarized krypton

March 11, 2016 — New scanning technology which will give a much clearer picture of lung disease has taken a major step forward thanks to scientists at The University of Nottingham.

The experts at the Sir Peter Mansfield Imaging Centre have developed a process using specially treated krypton gas as an inhalable contrast agent to make the spaces inside the lungs show up on a magnetic resonance imaging (MRI) scan. It is hoped the new process will eventually allow doctors to virtually see inside the lungs of patients.

Traditional MRI uses hydrogen protons in the body as molecular targets to give a picture of tissue, but this does not give a detailed picture of the lungs because they are full of air. Recent technological developments have led to a novel imaging methodology called inhaled hyperpolarized gas MRI that uses lasers to 'hyperpolarize' a noble (inert) gas which aligns (polarizes) the nuclei of the gas so it shows up on an MRI scan.

The work will make 3-D imaging using 'atomic spies' like helium, xenon or krypton possible in a single breath hold by the patient. Nottingham has pioneered hyperpolarized krypton MRI and is currently advancing this technology towards the clinical approval processes.

Hyperpolarized MRI research has been trying to overcome a problem with these noble gases retaining their hyperpolarized state for long enough for the gas to be inhaled, held in the lungs and scanned. Now in a paper published in the Proceedings of the National Academy of Sciences, the Nottingham team has developed a new technique to generate hyperpolarized krypton gas at high purity, a step that will significantly facilitate the use of this new contrast agent for pulmonary MRI.

Chair in Translational Imaging at the Sir Peter Mansfield Imaging Centre, Prof. Thomas Meersmann, said: "It is particularly demanding to retain the hyperpolarized state of krypton during preparation of this contrast agent. We have solved a problem by using a process that is usually associated with clean energy-related sciences. It's called catalytic hydrogen combustion. To hyperpolarize the krypton-83 gas we diluted it in molecular hydrogen gas for the laser pumping process. After successful laser treatment the hydrogen gas is mixed with molecular oxygen and literally exploded it away in a safe and controlled fashion through a catalyzed combustion reaction.

"Remarkably, the hyperpolarized state of krypton-83 survives the combustion event. Water vapor, the sole product of the 'clean' hydrogen reaction, is easily removed through condensation, leaving behind the purified laser-polarized krypton-83 gas diluted only by small remaining quantities of harmless water vapor. This development significantly improves the potential usefulness of laser-pumped krypton-83 as MRI contrast agent for clinical applications."

This new technique can also be used to hyperpolarize another useful noble gas, xenon-129, and may lead to a cheaper and easier production of this contrast agent.

As part of a recent Medical Research Council funding award, hyperpolarized krypton-83 is currently being developed for whole body MRI at high magnetic field strength in the Sir Peter Mansfield Imaging Centre's large 7 Tesla scanner. Studies will be carried out first on healthy volunteers before progressing to patient trials at a later phase.

For more information: www.pnas.org


Related Content

News | Stroke

March 11, 2026 — Brainomix, a provider of AI-powered imaging tools for stroke and lung fibrosis, has announced the ...

Time March 11, 2026
arrow
Feature | Artificial Intelligence | Kyle Hardner

Once considered an adjunct brain cancer therapy and a last-resort treatment, noninvasive radiosurgery has evolved ...

Time March 09, 2026
arrow
News | Radiation Oncology

March 4, 2026 — Lunit has announced that 21 studies featuring its AI solutions will be presented at the European ...

Time March 05, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

March 4, 2026 — The U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to Bayer for the expanded ...

Time March 04, 2026
arrow
News | Artificial Intelligence

March 2, 2026 — RadNet, Inc. has acquired Gleamer SAS, a radiology AI company based in Paris, France. Gleamer will be ...

Time March 03, 2026
arrow
News | HIMSS

March 3, 2026 — MedDream will present its cloud-native, AI-ready universal DICOM viewer in the Amazon Web Services (AWS) ...

Time March 03, 2026
arrow
News

Feb. 26, 2026 — GE HealthCare and UCSF Health have announced a 10-year Care Alliance collaboration focused on ...

Time March 02, 2026
arrow
News | Remote Viewing Systems

Feb. 26, 2026 — DeepHealth, Inc., a provider of AI-powered health informatics and a wholly owned subsidiary of RadNet ...

Time February 27, 2026
arrow
News | FDA

Feb. 26, 2026 — The U.S. Food and Drug Administration (FDA) has given 510(k) class II clearance of qXR-Detect, the ...

Time February 26, 2026
arrow
News | Contrast Media

Feb. 23, 2026 — Bracco, a global leader in diagnostic imaging, recently announced that the U.S. Food and Drug ...

Time February 24, 2026
arrow
Subscribe Now